| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |